Save
How to Measure the Benefit of Chemotherapy-Free Interval in a Trial with Maintenance Targeted Therapy? The Importance Combined Endpoints
ESGO eAcademy, Bradley Monk, 116819
How to Define Platinum-Resistance or Sensitivity after Several Lines of Treatment?
ESGO eAcademy, Jonathan Ledermann, 116818
Debate: Platinum-Free Interval is Still a Valid Tool in Guiding Treatment Decision - CON
ESGO eAcademy, Sandro Pignata, 116817
Debate: Platinum-Free Interval is Still a Valid Tool in Guiding Treatment Decision - PRO
ESGO eAcademy, Mansoor Raza Mirza, 116816
Welcome and Introduction: The Changing Landscape of Clinical Trials in the Era of Targeted and Immunologic Therapies: Different Patient Selection, New Endpoints, New Responsible Criteria
ESGO eAcademy, Nicoletta Colombo, 116815
Possible role of robotics in ERAS
ESGO eAcademy, Eric Lambaudie, 105096
What is the place of sentinel procedures in gynecologic Oncology?
ESGO eAcademy, Rene H.M. Verheijen, 105095
Robotic single-site pelvic lymphadenectomy
ESGO eAcademy, Liliana Mereu, 106938
Endoscopic staging in early stage ovarian cancer
ESGO eAcademy, Eric Lambaudie, 106937
Key Lecture: Critical considerations on Robotic Surgery for the treatment of Endometrial Cancer
ESGO eAcademy, Angelo Maggioni, 105137
What progress is made and expected the coming decade in endoscopic (non-robotic) gynaecological surgery ?
ESGO eAcademy, Farr Nezhat, 105090
Single site robotic hysterectomy
ESGO eAcademy, Fatih Sendag, 105088
Compartment imaging with fluorescence
ESGO eAcademy, Rainer Kimmig, 105087
New robots and implementation
ESGO eAcademy, Rene H.M. Verheijen, 105086
Paraaortic lymphadenectomy and surgical approach
ESGO eAcademy, Fabrice Narducci, 105085
Robotic radical trachelectomy
ESGO eAcademy, M. Faruk Kose, 105084
Robotic-assisted radical hysterectomy: oncology outcomes
ESGO eAcademy, Vanna Zanagnolo, 105083
Key lecture: Radical hysterectomy: Overview of the different techniques of parametrial dissection
ESGO eAcademy, Rainer Kimmig, 105082
Abstracts for Meetings
ESGO eAcademy, Sean Kehoe, 108687
Clinical Trials
ESGO eAcademy, Sean Kehoe, 108688
Journals for Gynaecological Oncology
ESGO eAcademy, Sean Kehoe, 108689
Other Publications
ESGO eAcademy, Sean Kehoe, 108690
The Oral Presentation
ESGO eAcademy, Sean Kehoe, 108691
Constructing a Paper
ESGO eAcademy, Christina Fotopoulou, 108692
The Poster Presentation
ESGO eAcademy, Christina Fotopoulou, 108693
Why Are Papers Rejected?
ESGO eAcademy, Christina Fotopoulou, 108694
Statistical Basic Facts
ESGO eAcademy, Mariana Díaz Almirón, 108695
European Reference Network
ESGO eAcademy, Francois Golfier, 99309
Future Perspectives in Gestational Trophoblastic Disease
ESGO eAcademy, Leon Massuger, 99308
PSTT/ETT
ESGO eAcademy, Barry Hancock, 99307
When EMACO Does Not Cure
ESGO eAcademy, Michael Seckl, 99305
Case Report Hi Dose
ESGO eAcademy, Kirsty Balachandran, 99304
Treatment of High Risk Gestational Trophoblastic Disease
ESGO eAcademy, John Tidy, 99303
Case: High Risk Gestational Trophoblastic Disease
ESGO eAcademy, Mireille Vree, 99302
Treatment of Low Risk Gestational Trophoblastic Disease
ESGO eAcademy, John Coulter, 99301
Case: MTX Resistance
ESGO eAcademy, Sam Schoenmakers, 99300
Histologic and Immunohistochemic Features of Trophoblastic Disease
ESGO eAcademy, Sophie Patrier, 99299
Case Report Pathology
ESGO eAcademy, Gwendoline Side-Pfennig, 99298
HCG in Gestational Trophoblastic Disease
ESGO eAcademy, Teun van Herwaarden, 99295
Case: Clinical Consequences of Different hCG Assays
ESGO eAcademy, Yalck Eysbouts, 99294
History of Gestational Trophoblastic Disease
ESGO eAcademy, Rene H.M. Verheijen, 99293
Immunotherapy Represents the Future for Ovarian Cancer
ESGO eAcademy, Bradley Monk, 96876
Immunotherapy Has Never Worked and Will Never Work in Ovarian Cancer
ESGO eAcademy, Eric Pujade-Lauraine, 96875
How To Negotiate Support with Pharma Companies for Sponsored Trials
ESGO eAcademy, Andreas Du Bois, 96873
How To Write a Grant for Academic Trials (Investigator-Initiated)
ESGO eAcademy, Sandro Pignata, 96872
The Hurdles of Conducting Trials across Different Countries: Focus on EU Regulations and Differences Which May Constitute Barriers to Run an ENGOT Trial
ESGO eAcademy, Jacobus Pfisterer, 96871
The Challenge of Initiating a National Cooperative Trial Group: Tricks and Tips
ESGO eAcademy, Mansoor Raza Mirza, 96870
Outside EU Regulations: Activating a Study in Switzerland
ESGO eAcademy, Cristiana Sessa, 96983
Managing Depression in Cancer Patients
ESGO eAcademy, Madeline Li & Gary Rodin, 63587
Reversing Mutated p53 to Wild Type
ESGO eAcademy, Sevilay Altintas, 63068
Inhibiting the Gain-of-Function of Mutated p53
ESGO eAcademy, Nicole Concin, 63067
Why Signatures Miss the Goal in Ovarian Cancer
ESGO eAcademy, MICHAEL BIRRER, 63066
Why Signatures Are the Best Way to Identify Subgroups in Ovarian Cancer
ESGO eAcademy, Charlie Gourley, 63065
The Tricky Decision to Allow Cross-Over or Not in a Trial
ESGO eAcademy, Bradley J. Monk, 63064
Funding Options, Legal Aspect and Insurance Hurdles, How To Select Centers for Surgical Trials?
ESGO eAcademy, Jacobus Pfisterer, 63060
What Are the Endpoints and Do We Have the Right Questionnaires for QOL? What Are the Open Questions in Relapse Ovarian Cancer?
ESGO eAcademy, Philip Harter, 63061
Anaesthetic complications
ESGO eAcademy, Oliver Groll, 63116
Injury of the gastrointestinal tract
ESGO eAcademy, Gökhan Yagci, 63094
Robotic debulking surgery
ESGO eAcademy, Javier Magrina, 63093
EU reimbursement update and the role of medical expertise in Driving Dr.G change
ESGO eAcademy, Susanne Habetha, 63134
Chance of cost reduction and increase of efficiency in robotic surgery
ESGO eAcademy, Petur Reynisson, 63133
Cost analysis in endometrial cancer patients
ESGO eAcademy, Frederic Goffin, 63132
Cost evaluation (French analysis)
ESGO eAcademy, Eric Lambaudie, 63131
How to implement a registry?
ESGO eAcademy, Eric Lambaudie, 63092
The 'Art of Docking': Key for successful robotic surgery
ESGO eAcademy, Henrik Falconer, 63130
Robotic skills assessment: to score or not score ?
ESGO eAcademy, Henk W.R. Schreuder, 63088
Compartment visualization in embryologically defined surgery
ESGO eAcademy, Martin Heubner, 63129
Education in robotics: The U.S. experience
ESGO eAcademy, Gokhan S. Kilic, 63089
Applicability and feasibility of laparoscopic surgery of uterine cancer in patients with BMI under 30. Evaluation of a policy in favor of minimal invasive surgery in a single center
ESGO eAcademy, Denis Querleu, 63126
Perioperative morbidity and outcome analysis of robotically assisted laparoscopic radical hysterectomy
ESGO eAcademy, Fabrice Narducci, 63125
Robotic surgery and technique of radical hysterectomy in cervical and endometrial cancer
ESGO eAcademy, Angelo Maggioni, 63124
Evidence for adequate quality in radical hysterectomy by endoscopy
ESGO eAcademy, Roberto Tozzi, 63123
Robotic Surgery – less morbidity maintaining efficacy?
ESGO eAcademy, Loic Boulanger, 63143
Present and future development of robotic surgery in gynecology: Visions, expectations and demands
ESGO eAcademy, Ignace Vergote, 63083
SPECT/CT & sentinel node – an alternative to lymphadenectomy
ESGO eAcademy, Ronald P. Zweemer, 63121
Adhesion prevention in robotic myomectomy
ESGO eAcademy, Jasper Verguts, 63151
The need for guidelines and standards in robotic surgery
ESGO eAcademy, Dezita Taylor, 63157
New robotic systems
ESGO eAcademy, Rene H.M. Verheijen, 63138
Innovations of robotically assisted laparoscopy – Single port surgery
ESGO eAcademy, Fatih Sendag, 63136
RoundTable (Questions&Answers) of State of the Art Conference
ESGO eAcademy, Session Speakers, 62459
Patient´s expectations and perspectives about cancer care in ovarian cancer
ESGO eAcademy, Elena Ioana Braicu, 62458
Follow up of advanced stage invasive ovarian cancers
ESGO eAcademy, Gordon J.S. Rustin, 62457
Follow up of early stage invasive ovarian cancer, fertility sparing treatment
ESGO eAcademy, Rene H.M. Verheijen, 62456
Non epithelial ovarian tumours
ESGO eAcademy, Nicoletta Colombo, 62455
Borderline ovarian tumor follow up
ESGO eAcademy, Philippe Morice, 62454
Familial risk and its management
ESGO eAcademy, Usha Menon, 62453
Imaging strategies for follow up
ESGO eAcademy, Nandita de SOUZA, 62451
Imaging strategies for follow up
ESGO eAcademy, Manuela LUDOVISI, 62452
The Role of the Pathologist in Planning Follow up
ESGO eAcademy, Silvestro CARINELLI, 62450
The Role of Biomarkers in the Follow up in Ovarian Cancer
ESGO eAcademy, Massimo GION, 62449
Take home message of State of the Art Conference
ESGO eAcademy, Rainer Kimmig, 62446
RoundTable (Questions&Answers) of State of the Art Conference
ESGO eAcademy, Panel, 62444
Follow up of special histotypes including sarcomas
ESGO eAcademy, Nicholas Reed, 62443
Follow up after the treatment of endometrial cancer
ESGO eAcademy, ENRICO SARTORI, 62442
Endometrial cancer: Familial risk and its management
ESGO eAcademy, Usha Menon, 62441
Imaging strategies in the follow-up of endometrial cancer
ESGO eAcademy, Nandita de SOUZA, 62439
Imaging strategies for follow up
ESGO eAcademy, Manuela LUDOVISI, 62440
The Role of the Pathologist in Planning Follow up
ESGO eAcademy, Sigurd Lax, 62438
Take home message of State of the Art Conference
ESGO eAcademy, Tiziano Maggino, 62434
Take home message of State of the Art Conference
ESGO eAcademy, David Cibula, 62435

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings